Brief: First Wave BioPharma Announces Expansion Of Adrulipase Portfolio
25/01/2023 13:05
Jan 25 (Reuters) - First Wave BioPharma Inc FWBI.O :
* FIRST WAVE BIOPHARMA ANNOUNCES EXPANSION OF ADRULIPASE
INTELLECTUAL PROPERTY PORTFOLIO
* FIRST WAVE BIOPHARMA INC - UPON IND CLEARANCE, FIRST WAVE
EXPECTS TO INITIATE A PHASE 2 TRIAL AT BEGINNING OF 2023
Source text for Eikon: ID:nGNX5YqmWH
Further company coverage: FWBI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GridAI Technologies
See all newsBrief: Gridai Technologies Corp - Enters $2.54 Million Private Placement Of Shares And Warrants - SEC Filing
Brief: IBN Announces Latest Episode Of The Techmediawire Podcast Featuring Marshall Chapin, CEO Of Grid Ai Corp.
Brief: Entero Therapeutics Terminated Interim CEO And Chairman Richard Joel Paolone Effective Immediately - SEC Filing
Brief: Entero Therapeutics Inc - Now Offering 15.2 Million Shares Of Common Stock
Brief: Entero Therapeutics Inc Subsidiary Immunogenx Enters Settlement Agreement